Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis

NCT01739660 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease Stage 5

Interventions

DRUG: Pegloticase

Sponsor

Savient Pharmaceuticals